Disparities in prescribing of sodium-glucose co-transporter-2 (SGLT2) inhibitors and DPP-4 inhibitors in people with Type 2 diabetes and chronic kidney disease (CKD)

Disparities in prescribing of sodium-glucose co-transporter-2 (SGLT2) inhibitors and DPP-4 inhibitors in people with Type 2 diabetes and chronic kidney disease (CKD)

Bibliographic Details
Main Authors: Shah, S, Whyte, MB, McGovern, A, Van Vlymen, JN, Hinton, W, Munro, N, de Lusignan, S
Format: Conference item
Language:English
Published: Wiley 2018

Similar Items